disorder

(redirected from coagulation disorder)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

disorder

[dis′ȯrd·ər]
(crystallography)
Departures from regularity in the occupation of lattice sites in a crystal containing more than one element.
References in periodicals archive ?
We conducted a retrospective study of 6, 966 patients who had undergone tonsillectomy or adenotonsillectomy to evaluate the incidence and clinical features of previously unidentified coagulation disorders in patients who experienced postoperative hemorrhage (n = 201).
Analysis of the coagulation disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
Coagulation disorders should be considered in some cases of ischemic colitis that are thought to be idiopathic.
Important Safety Information THERAKOS[TM] Photopheresis is not appropriate for patients who cannot tolerate extracorporeal volume loss or shifts, or patients with coagulation disorders.
Professor Heimburger was a pioneer in improving the care for patients with coagulation disorders.
it will also be used for the management of bleeding disorders: intra-and postoperative examination (intensive care units) in case of injury (trauma, emergency), transplantation, or for other tests of coagulation disorders.
KING OF PRUSSIA, Pennsylvania, April 3, 2013 /PRNewswire/ -- As part of its ongoing commitment to the global coagulation disorders community, CSL Behring will again donate factor product to the World Federation of Hemophilia (WFH) in connection with World Hemophilia Day this month.
Thrombocytopenia, anemia, congenital infection, coagulation disorders, food allergy, breast milk, probiotics, fungal infections, and chorioamnionitis are some of the topics addressed.
The patient had no family history of coagulation disorders.
Last year's star exporter was Hartlepool's Hart Biologicals, which manufactures and supplies biological reagents for the monitoring of blood coagulation disorders, oral anticoagulants and anti-platelet drugs in doctors' surgeries, laboratories and hospitals.
Most clinicians do not have onsite access to the level of expertise required to manage hemophilia A and B, Von Willebrand disease, factor deficiencies, and rare platelet and coagulation disorders such as acquired bleeding diastheses, and thrombotic disorders.
In addition, Novo Nordisk has a leading position within areas such as coagulation disorders, growth disorders and hormone replacement therapy.